Clinical trial
Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to…
NCT00207402 · Brooke Army Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00207402 |
|---|---|
| Title | Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin |
| Official title | A Pilot Trial of Combination Therapy With Interferon Alfacon1, Ribavirin, & Rosiglitazone in a Group of Insulin Resistant, Chronic Hepatitis C, GT 1 Patients Who Are Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin |
| Lead sponsor | Brooke Army Medical Center, U.S. Fed |
| Collaborators | InterMune Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | rosiglitazone |
| Enrollment | 34 |
| Start date | Oct 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: